Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (panIN): Additional evidence for a recently proposed model of progression

Modern Pathology

Volumn 15, Issue 4, 2002, Pages 441-447

  Klein, Walter M ^a   Hruban, Ralph H ^a   Klein Szanto, Andres J P ^b   Wilentz, Robb E ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Ki 67 pancreas; Pancreatic intraepithelial neoplasia; PanIN; Proliferation

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67; PROTEIN P16;

ANTIBODY LABELING; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DYSPLASIA; HISTOLOGY; HUMAN; HUMAN TISSUE; LABELING INDEX; ONCOGENE K RAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PANCREATIC INTRAEPITHELIAL NEOPLASIA; POINT MUTATION; PRECANCER; PRIORITY JOURNAL; RELIABILITY; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MODELS, BIOLOGICAL; PANCREATIC DUCTS; PANCREATIC NEOPLASMS;

EID: 0036230171     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880544     Document Type: Article

References (30)

1. Pancreatic intraepithelial neoplasia: A new nomenclature and classification system for pancreatic duct lesions
2. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
3. Inactivation of the p16 (INK4A) tumor suppressor gene in pancreatic duct lesions: Loss of intranuclear expression
4. Overexpression of the p53 protein in adenocarcinoma of the pancreas
5. Immunohistochemical evaluation of HER-2/neu oncogene expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms
6. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation
7. Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease
8. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
9. Expression of p53 nucleophosphoprotein in in situ pancreatic ductal adenocarcinoma: An immunohistochemical analysis of 100 cases [abstract]
10. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
11. Genetic progression in pancreatic ducts
12. The Ki-67 protein: From the known and unknown
13. Proliferation index and karyometric features of pancreatic intraductal proliferative lesions
14. Proliferation markers in breast carcinoma: Mitotic figure count, s-phase fraction, proliferating cell nuclear antigen, Ki-67 and Mib-l
15. MIBI, a promising marker for the classification of cervical intraepithelial neoplasia
16. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type
17. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth
18. Markers of cell proliferation in normal epithelia and dysplastic leukoplakias of the oral cavity
19. Proliferating cell nuclear antigen as a marker of cell kinetics in aberrant crypt foci, hyperplastic polyps, adenomas, and adenocarcinomas of the human colon
20. Apoptotic and proliferative activity in the neoplastic progression of Barrett's oesophagus: A comparative study
21. E2F-l: A proliferative marker of breast neoplasia
22. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma
23. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: An immunohistochemical study
24. Progression model for pancreatic cancer
25. Morphological lesions associated with human primary invasive nonendocrine pancreas cancer
26. Relation of pancreatic duct hyperplasia to carcinoma
27. Varying grades of epithelial atypia in the pancreatic ducts of humans. Classification based on morphometry and multivariate analysis and correlated with Mth positive reactions of carcinoembryonic antigen
28. Progression of pancreatic intraductal neoplasias (high-grade PanIN) to infiltrating adenocarcinoma of the pancreas
29. Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinoma
30. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis